Raynaud syndrome.

Suppr

超能文献

作者信息

Blunt R J, Porter J M

出版信息

Semin Arthritis Rheum. 1981 May;10(4):282-308. doi: 10.1016/0049-0172(81)90006-8.

DOI:10.1016/0049-0172(81)90006-8

PMID:6166048

Abstract

摘要

相似文献

Raynaud syndrome.

Semin Arthritis Rheum. 1981 May;10(4):282-308. doi: 10.1016/0049-0172(81)90006-8.

Raynaud's syndrome and small vessel arteriopathy.

Semin Vasc Surg. 1993 Mar;6(1):56-65.

The mechanisms of Raynaud's phenomenon: Part 2.

Med J Aust. 1974 Sep 7;2(10):367-75. doi: 10.5694/j.1326-5377.1974.tb70840.x.

Connective tissue disorders associated with vasculitis and vaso-occlusive disease of the hand.

Hand Clin. 2015 Feb;31(1):63-73. doi: 10.1016/j.hcl.2014.09.006. Epub 2014 Nov 25.

The diagnosis and treatment of Raynaud's phenomenon.

Surgery. 1975 Jan;77(1):11-23.

[Diagnosis and therapy of the acral ischemia syndrome].

Dtsch Med Wochenschr. 1985 Sep 20;110(38):1463-8. doi: 10.1055/s-2008-1069030.

[Raynaud's syndrome: diagnosis and therapy].

Ther Umsch. 1985 Oct;42(10):671-7.

Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?

Neth J Med. 1984;27(9):322-6.

Hand angiography and Raynaud's syndrome.

Rofo. 1977 Jul;127(1):30-7. doi: 10.1055/s-0029-1230652.

Reserpine and Raynaud's phenomenon.

N Engl J Med. 1971 Jul 29;285(5):290-1. doi: 10.1056/NEJM197107292850513.

引用本文的文献

Vasodilators for primary Raynaud's phenomenon.

Cochrane Database Syst Rev. 2021 May 17;5(5):CD006687. doi: 10.1002/14651858.CD006687.pub4.

[Not Available].

Can Fam Physician. 1983 Feb;29:296-9.

Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.

Br Med J (Clin Res Ed). 1982 Oct 16;285(6348):1069-71. doi: 10.1136/bmj.285.6348.1069.

Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.

Br Med J (Clin Res Ed). 1983 Apr 16;286(6373):1262-4. doi: 10.1136/bmj.286.6373.1262.

Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial.

Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):113S-116S. doi: 10.1111/j.1365-2125.1983.tb02119.x.

Raynaud's syndrome and carpal tunnel syndrome.

Postgrad Med J. 1985 Feb;61(712):161-2. doi: 10.1136/pgmj.61.712.161.

Prostaglandin E1 vasospastic disease and thermography.

Ann Rheum Dis. 1985 Feb;44(2):73-8. doi: 10.1136/ard.44.2.73.

A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.

Ann Rheum Dis. 1985 Jan;44(1):30-3. doi: 10.1136/ard.44.1.30.

Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.

Rheumatol Int. 1986;6(2):85-8. doi: 10.1007/BF00541510.

Upper extremity ischemia caused by small artery disease.

Ann Surg. 1987 Oct;206(4):521-8. doi: 10.1097/00000658-198710000-00013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Raynaud syndrome.

Semin Arthritis Rheum. 1981 May;10(4):282-308. doi: 10.1016/0049-0172(81)90006-8.

Raynaud's syndrome and small vessel arteriopathy.

Semin Vasc Surg. 1993 Mar;6(1):56-65.

The mechanisms of Raynaud's phenomenon: Part 2.

Med J Aust. 1974 Sep 7;2(10):367-75. doi: 10.5694/j.1326-5377.1974.tb70840.x.

Connective tissue disorders associated with vasculitis and vaso-occlusive disease of the hand.

Hand Clin. 2015 Feb;31(1):63-73. doi: 10.1016/j.hcl.2014.09.006. Epub 2014 Nov 25.

The diagnosis and treatment of Raynaud's phenomenon.

Surgery. 1975 Jan;77(1):11-23.

[Diagnosis and therapy of the acral ischemia syndrome].

Dtsch Med Wochenschr. 1985 Sep 20;110(38):1463-8. doi: 10.1055/s-2008-1069030.

[Raynaud's syndrome: diagnosis and therapy].

Ther Umsch. 1985 Oct;42(10):671-7.

Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?

Neth J Med. 1984;27(9):322-6.

Hand angiography and Raynaud's syndrome.

Rofo. 1977 Jul;127(1):30-7. doi: 10.1055/s-0029-1230652.

Reserpine and Raynaud's phenomenon.

N Engl J Med. 1971 Jul 29;285(5):290-1. doi: 10.1056/NEJM197107292850513.

引用本文的文献

Vasodilators for primary Raynaud's phenomenon.

Cochrane Database Syst Rev. 2021 May 17;5(5):CD006687. doi: 10.1002/14651858.CD006687.pub4.

[Not Available].

Can Fam Physician. 1983 Feb;29:296-9.

Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.

Br Med J (Clin Res Ed). 1982 Oct 16;285(6348):1069-71. doi: 10.1136/bmj.285.6348.1069.

Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.

Br Med J (Clin Res Ed). 1983 Apr 16;286(6373):1262-4. doi: 10.1136/bmj.286.6373.1262.

Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial.

Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):113S-116S. doi: 10.1111/j.1365-2125.1983.tb02119.x.

Raynaud's syndrome and carpal tunnel syndrome.

Postgrad Med J. 1985 Feb;61(712):161-2. doi: 10.1136/pgmj.61.712.161.

Prostaglandin E1 vasospastic disease and thermography.

Ann Rheum Dis. 1985 Feb;44(2):73-8. doi: 10.1136/ard.44.2.73.

A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.

Ann Rheum Dis. 1985 Jan;44(1):30-3. doi: 10.1136/ard.44.1.30.

Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.

Rheumatol Int. 1986;6(2):85-8. doi: 10.1007/BF00541510.

Upper extremity ischemia caused by small artery disease.

Ann Surg. 1987 Oct;206(4):521-8. doi: 10.1097/00000658-198710000-00013.